Ding, Y.; Liu, W. Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients With Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparisons. Acta Derm Venereol 2026, 106, adv-2025.